{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:07:33Z","timestamp":1790665653153,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Chronic lymphocytic leukemia (CLL) with cytogenetics findings, such as complex karyotype and deletions of <jats:italic>TP53<\/jats:italic> or <jats:italic>ATM<\/jats:italic>, is associated with adverse clinical outcomes. Additional chromosomal abnormalities further stratify patients into groups with diverse prognoses. Gain of 8q24 is one of the abnormalities considered as prognostically unfavorable. In our study, we performed a FISH analysis in an initial cohort of 303 consecutive CLL patients and determined the frequency of +8q to be 6.3\u00a0%. Our analysis confirmed the association with <jats:italic>TP53\/ATM<\/jats:italic> aberrations and CK, as the frequency of +8q reached 26.7\u00a0% in an extended del<jats:italic>TP53\/ATM<\/jats:italic>+CK cohort. M-FISH analysis enabled the identification of partner chromosomes where the segment of the duplicated 8q arm was localized. More detailed mapping of the gained 8q region using the M-BAND method determined the smallest amplified region 8q23-8qter. We observed significantly shorter overall survival (OS; 9.0 years in +8q-positive vs. 10.6 years in +8q-negative; p=0.02) and detected slightly higher MYC mRNA\/protein levels in +8q-positive vs. +8q-negative patients.<\/jats:p>","DOI":"10.3389\/fonc.2022.859618","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T04:40:47Z","timestamp":1656045647000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations"],"prefix":"10.3389","volume":"12","author":[{"given":"Eva","family":"Ondrou\u0161kov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Boh\u00fanov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krist\u00fdna","family":"Z\u00e1vack\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"\u010cech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"\u0160muha\u0159ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Boudn\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Or\u0161ulov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Panovsk\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Radov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doubek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Plevov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Jaro\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1182\/blood-2018-01-826008","article-title":"High-Risk Chronic Lymphocytic Leukemia in the Era of Pathway Inhibitors: Integrating Molecular and Cellular Therapies","volume":"132","author":"Dreger","year":"2018","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41408-018-0131-2","article-title":"Chronic Lymphocytic Leukemia Treatment Algorithm 2018","volume":"8","author":"Parikh","year":"2018","journal-title":"Blood Cancer J"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-873083","article-title":"Cytogenetic Complexity in Chronic Lymphocytic Leukemia: Definitions, Associations, and Clinical Impact","volume":"133","author":"Baliakas","year":"2019","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.6.1848.418k05_1848_1854","article-title":"Unmutated Ig V(H) Genes are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V100.4.1177.h81602001177_1177_1184","article-title":"Multivariate Analysis of Prognostic Factors in CLL: Clinical Stage, IGVH Gene Mutational Status, and Loss or Mutation of the P53 Gene are Independent Prognostic Factors","volume":"100","author":"Oscier","year":"2002","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26367","article-title":"Chronic Lymphocytic Leukemia: 2022 Update on Diagnostic and Therapeutic Procedures","volume":"96","author":"Hallek","year":"2021","journal-title":"Am J Hematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3324\/haematol.2019.239947","article-title":"Genomic Arrays Identify High-Risk Chronic Lymphocytic Leukemia With Genomic Complexity: A Multi-Center Study","volume":"106","author":"Leeksma","year":"2020","journal-title":"Haematologica"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-423517","article-title":"High-Resolution Genomic Profiling of Chronic Lymphocytic Leukemia Reveals New Recurrent Genomic Alterations","volume":"120","author":"Edelmann","year":"2012","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08789.x","article-title":"Genome-Wide DNA Profiling Better Defines the Prognosis of Chronic Lymphocytic Leukaemia","volume":"154","author":"Rinaldi","year":"2011","journal-title":"Br J Haematol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.217307","article-title":"Genomic Alterations in High-Risk Chronic Lymphocytic Leukemia Frequently Affect Cell Cycle Key Regulators and NOTCH1-Regulated Transcription","volume":"105","author":"Edelmann","year":"2020","journal-title":"Haematologica"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13106","article-title":"Karyotypic Complexity Rather Than Chromosome 8 Abnormalities Aggravates the Outcome of Chronic Lymphocytic Leukemia Patients With TP53 Aberrations","volume":"7","author":"Blanco","year":"2016","journal-title":"Oncotarget"},{"key":"B12","doi-asserted-by":"publisher","first-page":"106218","DOI":"10.1016\/j.leukres.2019.106218","article-title":"Complex Karyotype as a Predictor of High-Risk Chronic Lymphocytic Leukemia: A Single Center Experience Over 12 Years","volume":"85","author":"Kruzova","year":"2019","journal-title":"Leuk Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2008.07373.x","article-title":"Genome-Wide DNA Analysis Identifies Recurrent Imbalances Predicting Outcome in Chronic Lymphocytic Leukaemia With 17p Deletion","volume":"143","author":"Forconi","year":"2008","journal-title":"Br J Haematol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.845882","article-title":"Genomic Imbalance Defines Three Prognostic Groups for Risk Stratification of Patients With Chronic Lymphocytic Leukemia","volume":"55","author":"Houldsworth","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-005322","article-title":"Immunostimulatory Oligonucleotide-Induced Metaphase Cytogenetics Detect Chromosomal Aberrations in 80% of CLL Patients: A Study of 132 CLL Cases With Correlation to FISH, IgVH Status, and CD38 Expression","volume":"108","author":"Dicker","year":"2006","journal-title":"Blood"},{"key":"B16","volume-title":"An International System for Human Cytogenomic Nomenclature","author":"McGowan-Jordan","year":"2020"},{"key":"B17","doi-asserted-by":"publisher","first-page":"106288","DOI":"10.1016\/j.leukres.2019.106288","article-title":"PRIMA-1","volume":"89","author":"Jaskova","year":"2020","journal-title":"Leuk Res"},{"key":"B18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12032-019-1300-2","article-title":"Examination of Clonal Evolution in Chronic Lymphocytic Leukemia","volume":"36","author":"Koczkodaj","year":"2019","journal-title":"Med Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1053\/beha.2001.0157","article-title":"Lymphoid Neoplasms","volume":"14","author":"Oscier","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000707","article-title":"Cytogenetics in Chronic Lymphocytic Leukemia: ERIC Perspectives and Recommendations","volume":"6","author":"Baliakas","year":"2022","journal-title":"Hemasphere"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/nature15395","article-title":"Mutations Driving CLL and Their Evolution in Progression and Relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.826245","article-title":"\"Double-Hit\" Chronic Lymphocytic Leukemia, Involving the","volume":"11","author":"Nguyen-Khac","year":"2021","journal-title":"Front Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"a014407","DOI":"10.1101\/cshperspect.a014407","article-title":"MYC and the Control of Apoptosis","volume":"4","author":"McMahon","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/genes8060151","article-title":"MYC Deregulation in Primary Human Cancers","volume":"8","author":"Kalkat","year":"2017","journal-title":"Genes (Basel)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: The Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2014.08.006","article-title":"MYC Deregulation in Lymphoid Tumors: Molecular Mechanisms, Clinical Consequences and Therapeutic Implications","volume":"1846","author":"Sewastianik","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1013420107","article-title":"B-Cell Activating Factor and V-Myc Myelocytomatosis Viral Oncogene Homolog (C-Myc) Influence Progression of Chronic Lymphocytic Leukemia","volume":"107","author":"Zhang","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12734","article-title":"MYC in Germinal Center-Derived Lymphomas: Mechanisms and Therapeutic Opportunities","volume":"288","author":"Bisso","year":"2019","journal-title":"Immunol Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-284984","article-title":"The Lymph Node Microenvironment Promotes B-Cell Receptor Signaling, NF-kappaB Activation, and Tumor Proliferation in Chronic Lymphocytic Leukemia","volume":"117","author":"Herishanu","year":"2011","journal-title":"Blood"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a014365","article-title":"MYC Degradation","volume":"4","author":"Farrell","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B32","article-title":"C-MYC Involvement in Chronic Lymphocytic Leukemia (CLL): A Molecular and Cytogenetic Update","volume":"41","author":"Fonseka","year":"2015","journal-title":"J Assoc Genet Technol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.224121","article-title":"Clinical Characteristics and Outcomes of Richter Transformation: Experience of 204 Patients From a Single Center","volume":"105","author":"Wang","year":"2020","journal-title":"Haematologica"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-09-302174","article-title":"The Genetics of Richter Syndrome Reveals Disease Heterogeneity and Predicts Survival After Transformation","volume":"117","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hon.932","article-title":"Genomic Profiling of Richter's Syndrome: Recurrent Lesions and Differences With De Novo Diffuse Large B-Cell Lymphomas","volume":"28","author":"Scandurra","year":"2010","journal-title":"Hematol Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1309\/AJCPATRQWANW2O3N","article-title":"Cytogenetic and Flow Cytometry Evaluation of Richter Syndrome Reveals MYC, CDKN2A, IGH Alterations With Loss of CD52, CD62L and Increase of CD71 Antigen Expression as the Most Frequent Recurrent Abnormalities","volume":"143","author":"Woroniecka","year":"2015","journal-title":"Am J Clin Pathol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1675877","article-title":"The Role of MYC in the Transformation and Aggressiveness of 'Indolent' B-Cell Malignancies","volume":"61","author":"Filip","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018016048","article-title":"Activation of MYC, a Bona Fide Client of HSP90, Contributes to Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma","volume":"2","author":"Lee","year":"2018","journal-title":"Blood Adv"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24990","article-title":"\"Double-Hit\" Chronic Lymphocytic Leukemia: An Aggressive Subgroup With 17p Deletion and 8q24 Gain","volume":"93","author":"Chapiro","year":"2018","journal-title":"Am J Hematol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"a014373","DOI":"10.1101\/cshperspect.a014373","article-title":"C-MYC-Induced Genomic Instability","volume":"4","author":"Kuzyk","year":"2014","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0065-230X(02)84004-0","article-title":"The Myc Oncogene: MarvelouslY Complex","volume":"84","author":"Oster","year":"2002","journal-title":"Adv Cancer Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.859618\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T04:40:50Z","timestamp":1656045650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.859618\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":41,"alternative-id":["10.3389\/fonc.2022.859618"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.859618","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"article-number":"859618"}}